BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells

Zhou, X; Sun, T; Meng, YT; Luo, J; Chen, J; Xia, B; Zhang, ZH; Cheng, ZX; Wang, XR

Cheng, ZX (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Pain Management, 121 Jiang Jia Yuan, Nanjing 210011, Jiangsu, Peoples R China.; Wang, XR (corresponding author), Nanjing Med Univ, Dept Pharmacol, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.

ONCOLOGY REPORTS, 2021; 45 (5):

Abstract

The bromodomain and extra-terminal domain (BET) family proteins are essential epigenetic regulators in lung cancer. However, BET inhibitors have not h......

Full Text Link